Related Experiment Videos
Tumor board in gynecologic oncology
J T Santoso1, B Schwertner, R L Coleman
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Tennessee Cancer Institute, 1331 Union Avenue, Suite 800, Memphis, TN 38104, USA. jsantoso@utcancerinstitute.com
Summary
Weekly gynecologic oncology tumor conferences significantly impact patient care. These multidisciplinary discussions led to changes in diagnosis and treatment for nearly 7% of cases, improving cancer management.
Area of Science:
- Gynecologic Oncology
- Clinical Pathology
- Multidisciplinary Care
Background:
- Effective management of gynecologic cancers relies on accurate diagnosis and tailored treatment plans.
- Multidisciplinary tumor conferences are crucial for optimizing patient care strategies.
Purpose of the Study:
- To assess the impact of a weekly gynecologic oncology tumor conference on patient care management.
- To quantify the frequency and significance of changes in diagnosis and treatment resulting from tumor board discussions.
Main Methods:
- Retrospective review of 459 gynecologic oncology cases presented at tumor conferences (1998-2001).
- Comparison of pre- and post-conference pathology and diagnosis to identify discrepancies.
- Classification of discrepancies as major (affecting patient care) or minor.
Main Results:
- A total of 459 cases were reviewed, with an average of 3.7 cases per conference.
- Discrepancies were noted in 6.9% of cases (32/459), including 23 major and 9 minor discrepancies.
- The most frequent therapeutic changes following tumor board review were the addition of chemotherapy and surgery.
Conclusions:
- Gynecologic oncology tumor boards enhance patient care by integrating clinical information and refining diagnoses.
- Tumor board recommendations, particularly regarding chemotherapy and surgery, directly influence patient medical care and treatment outcomes.